Abrdn Healthcare Opportunities Fund (THQ) Fund Overview
Abrdn Healthcare Opportunities Fund (THQ) — price $17.67 (-2.27%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Abrdn Healthcare Opportunities Fund · THQ
Abrdn Healthcare Opportunities Fund (THQ) is a closed-end, balanced mutual fund managed by Tekla Capital Management LLC, investing in global public equity and debt securities within the healthcare sector.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $17.67 |
| Change on the day | -2.27% |
| Shares traded on the day | 163.0K |
Price & events
What is Abrdn Healthcare Opportunities Fund (THQ), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Abrdn Healthcare Opportunities Fund (THQ) is the company analyzed here. In Q2 FY2026 it reported revenue of $36M and net income of $25M.
What do the latest results show for Abrdn Healthcare Opportunities Fund (THQ)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $36M.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $36M | $25M | $0.60 (diluted) |
| Q2 FY2025 | $20M | -$61M | -$1.47 (diluted) |
| Q4 FY2024 | $52M | $66M | $1.60 (diluted) |
What are the financial strengths and risks for Abrdn Healthcare Opportunities Fund (THQ)?
Short answer · as of
The distress and quality screens read Altman Z 1.75 · Piotroski F 3. Trailing ratios: ROE -4.0% · ROA -3.1% · current ratio 0.06 · earnings yield -3.6% · free-cash-flow yield -0.1%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 1.75 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-4.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held THQ in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported THQ in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Abrdn Healthcare Opportunities Fund Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the THQ research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
How does Abrdn Healthcare Opportunities Fund make money in financial services?
Abrdn Healthcare Opportunities Fund (THQ) generates returns and revenue primarily through its investment activities within the financial services sector. As a closed-end fund, it aims to increase its net asset value (NAV) through capital appreciation of its equity investments in global healthcare companies, including those in pharmaceuticals, biotechnology, and healthcare services.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 9 figures on this page — 7 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com